Burkitt lymphoma is one of the most fascinating and rapidly progressing malignancies in modern medicine. Although it represents a relatively uncommon form of lymphoma, its extraordinary growth rate, unique molecular characteristics, and remarkable response to treatment have made it an important subject of study in hematology, oncology, immunology, and molecular biology.
This book, "Burkitt Lymphoma: Biology, Diagnosis, Treatment, and Future Perspectives," has been developed to provide a comprehensive understanding of this aggressive B-cell malignancy. It explores the disease from fundamental biological concepts to advanced clinical management strategies, offering valuable knowledge for students, researchers, healthcare professionals, and anyone interested in cancer biology.
The journey begins with the historical discovery of Burkitt lymphoma and progresses through its epidemiology, classification, cellular origin, molecular mechanisms, and relationship with genetic abnormalities such as MYC gene rearrangement. The book explains how alterations in cellular growth regulation, immune responses, and viral interactions contribute to the development of this disease.
A major focus of this work is the diagnostic approach to Burkitt lymphoma. Modern diagnostic techniques, including histopathology, immunophenotyping, cytogenetics, fluorescence in situ hybridization (FISH), and molecular analysis, are discussed in detail. Understanding these methods is essential because accurate diagnosis allows appropriate treatment selection and improves patient outcomes.
The book also provides an extensive discussion of clinical manifestations, staging systems, prognostic factors, and therapeutic strategies. Special attention is given to intensive chemotherapy protocols, targeted therapies, central nervous system management, supportive care, and the challenges associated with relapsed or refractory disease.
Burkitt lymphoma represents an excellent example of how discoveries in molecular biology can transform patient care. The identification of MYC abnormalities, advances in genomic technologies, development of immunotherapies, and emergence of precision medicine approaches have significantly changed our understanding of this disease. Future directions, including artificial intelligence, liquid biopsy, cellular therapies, and personalized treatment approaches, offer new hope for improved outcomes.
Despite remarkable progress, important challenges remain. Access to early diagnosis and effective treatment continues to vary worldwide, particularly in regions where endemic Burkitt lymphoma is common. Continued international research collaboration and improvements in healthcare infrastructure are essential for reducing the global burden of this disease.
This book is written with the aim of presenting complex scientific concepts in a clear, organized, and accessible manner. Each chapter builds upon the previous one, creating a complete overview of Burkitt lymphoma—from basic biology to future innovations.
I hope this work inspires deeper interest in hematological cancers and contributes to a better understanding of one of the most remarkable diseases in cancer medicine. Through continued research, collaboration, and innovation, the goal of achieving more effective, safer, and universally accessible treatments for Burkitt lymphoma moves closer to reality.
— Author
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. Print on Demand. N° de réf. du vendeur I-9798186894773
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798186894773
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur L2-9798186894773
Quantité disponible : Plus de 20 disponibles